Corrigendum to “Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway” [The Veterinary Journal 196 (2013) 414–423] (The Veterinary Journal (2013) 196(3) (414–423), (S109002331200456X), (10.1016/j.tvjl.2012.10.021));Feline mammary carcinoma stem cells are tumorigenic, radioresistant, chemoresistant and defective in activation of the ATM/p53 DNA damage pathway

Veterinary Journal

Volumn 196, Issue 3, 2013, Pages 414-423

  Pang, L Y ^a   Blacking, T M ^a   Else, R W ^a   Sherman, A ^a   Sang, H M ^a   Whitelaw, B A ^a   Hupp, T R ^b   Argyle, D J ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer stem cell; Epithelial mesenchymal transition; Feline mammary carcinoma; P53

Indexed keywords

ATM PROTEIN; CD133 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL INVASION; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; MOUSE; NONHUMAN; RADIOSENSITIVITY;

FELIDAE;

EID: 84879411487     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2021.105744     Document Type: Erratum

References (32)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Science of the United States of America 2003, 100:3983-3988.
2. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Current Biology 1998, 8:145-155.
3. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
4. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Research 2006, 66:7843-7848.
5. Barbieri F., Wurth R., Ratto A., Campanella C., Vito G., Thellung S., Daga A., Cilli M., Ferrari A., Florio T. Isolation of stem-like cells from spontaneous feline mammary carcinomas: Phenotypic characterization and tumorigenic potential. Experimental Cell Research 2012, 318:847-860.
6. Blacking T.M., Waterfall M., Argyle D.J. CD44 is associated with proliferation, rather than a specific cancer stem cell population, in cultured canine cancer cells. Veterinary Immunology and Immunopathology 2011, 141:46-57.
7. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997, 3:730-737.
8. Cervantes-Arias A., Pang L.Y., Argyle D.J. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype. Veterinary and Comparative Oncology 2012, 10.1111/j.1476-5829.2011.00313.x.
9. cip1/waf1. Science 2000, 287:1804-1808.
10. El-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Wang Y.-S., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Research 1994, 54:1169-1174.
11. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
12. Hayes A.A., Mooney S. Feline mammary tumors. Veterinary Clinics of North America. Small Animal Practice 1985, 15:513-520.
13. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
14. Hupp T.R., Lane D.P., Ball K.L. Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochemical Journal 2000, 352:1-17.
15. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 1991, 51:6304-6311.
16. Kunzi-Rapp K., Genze F., Kufer R., Reich E., Hautmann R.E., Gschwend J.E. Chorioallantoic membrane assay: Vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. Journal of Urology 2001, 166:1502-1507.
17. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
18. Norval M., Maingay J., Else R.W. Characteristics of a feline mammary carcinoma cell line. Research in Veterinary Science 1985, 39:157-164.
19. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
20. Overley B., Shofer F.S., Goldschmidt M.H., Sherer D., Sorenmo K.U. Association between ovarihysterectomy and feline mammary carcinoma. Journal of Veterinary Internal Medicine 2005, 19:560-563.
21. Pang L.Y., Argyle D.J. Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology. Biochimica et Biophysica Acta 2009, 1792:380-391.
22. Pang L.Y., Bergkvist G.T., Cervantes-Arias A., Yool D.A., Muirhead R., Argyle D.J. Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. The Veterinary Journal 2012, 193:46-52.
23. Pang L.Y., Cervantes-Arias A., Else R.W., Argyle D.J. Canine mammary cancer stem cells are radio- and chemo-resistant and exhibit an epithelial-mesenchymal transition phenotype. Cancers 2011, 3:1744-1762.
24. Perry M.M. A complete culture system for the chick embryo. Nature 1988, 331:70-72.
25. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. Journal of Biological Chemistry 1998, 273:5858-5868.
26. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Research 2003, 63:5821-5828.
27. Stoica G., Lungu G., Martini-Stoica H., Waghela S., Levine J., Smith R. Identification of cancer stem cells in dog glioblastoma. Veterinary Pathology 2009, 46:391-406.
28. WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proceedings of the National Academy of Science of the United States of America 1999, 96:9089-9094.
29. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigation 2000, 18:781-792.
30. Wilson H., Huelsmeyer M., Chun R., Young K.M., Friedrichs K., Argyle D.J. Isolation and characterisation of cancer stem cells from canine osteosarcoma. The Veterinary Journal 2008, 175:69-75.
31. Zappulli, V., De Zan, G., Cardazzo, B., Bargelloni, L., Castagnaro, M., 2005. Feline mammary tumours in comparative oncology. Journal of Dairy Research 72, 98-106.
32. Zhao T., Xu Y. P53 and stem cells: New developments and new concerns. Trends in Cell Biology 2010, 20:170-175.